Thomas Stauffer Larsen

26PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Dec 08, 2025
Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials.

Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric

|Oct 20, 2025
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.

Martin Hutchings, Anna Sureda, Francesc Bosch

|Aug 04, 2025
Monitoring ctDNA in aggressive B-cell lymphoma: a prospective correlative study of ctDNA kinetics and PET-CT metrics.

Gayaththri Vimalathas, Marcus Høy Hansen, Oriane Cédile

|Jul 13, 2025
Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study.

Freja Tang Severinsen, Mikkel Runason Simonsen, Eva Futtrup Maksten

Pageof 5